Covid-19: Maldives approves
China's Sinopharm vaccine for
The Covid-19 vaccine developed by China's Sinopharm has been
approved for emergency use in the Maldives, the Maldives Food
and Drug Administration (MFDA) announced at a press
conference on Monday.
The vaccine made by China National Pharmaceutical Group
(Sinopharm) will be given to people aged between 18 and 60,
local media reported, citing an official at the MFDA. The MFDA
also announced that the vaccine made by Pfizer has also been
approved for emergency use, the Xinhua news agency reported.
The Covishield vaccine based on a formula by AstraZeneca and
Oxford University and manufactured by the Serum Institute of
India was approved for emergency use in late January.
The government of Maldives has been vaccinating its population
against the pandemic since February 1, prioritising frontline
health workers and other high-risk groups. Vaccinations are
available free of charge to residents over the age of 18, including
undocumented immigrants. Read More